Integras Partners LLC

Position in ABBV — AbbVie Inc.

CIK 2055384 Alpharetta, GA

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$3,854,621

+$612,498 QoQ

Shares Held

15,318

+2.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

4.44%

of 13F equity value

Holder Rank

#1,482

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Integras Partners LLC holds $14,287,432 across 5 Drug Manufacturers - General names. ABBV ranks #1 (27.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	15,318	$3,854,621
2	AMGN	Amgen Inc	9,675	$3,503,511
3	BMY	Bristol Myers Squibb Co	59,474	$3,426,891
4	GILD	Gilead Sciences, Inc.	24,946	$3,151,677
5	JNJ	Johnson & Johnson	1,381	$350,732

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,854,621	15,318	+2.8%	Shares	Sole	2026-07-24
2026-03-31	$3,242,123	14,907	+1.5%	Shares	Sole	2026-05-12
2025-12-31	$3,355,604	14,686	-8.7%	Shares	Sole	2026-01-29
2025-09-30	$3,724,552	16,086	+4.1%	Shares	Sole	2025-10-23
2025-06-30	$2,868,571	15,454	-0.7%	Shares	Sole	2025-08-12
2025-03-31	$3,260,969	15,564	-1.2%	Shares	Sole	2025-05-14
2024-12-31	$2,798,419	15,748	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.